Dissertation > Excellent graduate degree dissertation topics show

Study on the Decision-Making Model of the Hepatitis B Immunization among the People Over 15 Years Old in China

Author: XiaoHeWei
Tutor: TanHongZhuan;ZhangShunXiang
School: Central South University
Course: Epidemiology and Biostatistics,
Keywords: Hepatitis B Vaccine Immunization strategy Decision Tree and Markov model
CLC: R392.1
Type: Master's thesis
Year: 2011
Downloads: 39
Quote: 0
Read: Download Dissertation

Abstract


Objective To establish multistage Decision tree-Markov model of the hepatitis B immunization strategies for the people over 15 years old in China, and selected the best hepatitis B vaccination strategy for different groups of people. The study results can provide relevant departments with statistical basis for hepatitis B immunization strategies making.Methods The cost variables for HBV-infected were obtained from the investigation of the economic burden of hepatitis B-related diseases. The parameters of hepatitis B virus markers (HBVM) positive rate and positive rate of anti-HBs after vaccination were got through the Meta analysis. At the same time, other relevant factors were also considered, such as vaccination coverage, the new infection rate of hepatitis B vaccine, vaccination costs, screening costs, the discount rate, the conversion rate after HBV infection. Build multistage Decision tree-Markov model of the hepatitis B immunization strategies for the people over 15 years old in China by TreeAge Pro 2009 decision analysis software, and then finish cost-benefit analysis by TreeAge 2009 software. We used benefit-cost (BCR) to select the best hepatitis B vaccination strategy for different groups of people. We adopted sensitivity analysis to explore the main influencing factors on the best vaccination strategy.Results 1. The strategy of immunization of hepatitis B for people over the age of 15 is that selective vaccination is better than universal vaccination, and the BCR of selective vaccination was greater than 1, the BCR of universal vaccination less than 1.2. The optimizing immunization strategy for people of over 15 years is inoculating three 10μg vaccines after screening the markers anti-HBs, HBsAg and HBc according the program of 0,1 and 6 months. BCR of the optimizing strategy of age group 15-19 years is 2.40, and cost is 1229.59 RMB, benefit is 2950.75 RMB, net benefit is 1721.16 RMB. BCR of the optimizing strategy of age group 20-29 years is 3.22, and cost is 862.56 RMB, benefit is 2774.04 RMB, net benefit is 1911.49 RMB. BCR of the optimizing strategy of age group 30-39 years is 3.81, and cost is 680.09 RMB, benefit is 2591.16 RMB, net benefit is 1191.07 RMB. BCR of the optimizing strategy of age group 40-49 years is 3.98, and cost is 5421.81 RMB, benefit is 2157.92 RMB, net benefit is 1615.12 RMB. BCR of the optimizing strategy of age group over 50 years is 3.22, and cost is 290.16 RMB, benefit is 935.20 RMB, net benefit is 645.04 RMB. BCR of each age group increases with increasing age, but the benefit of each group decreases with increasing age. Those results suggest that investment in the lower age group will have greater social benefits.3. Decision tree-Markov model and cost-benefit analysis can comprehensive evaluate the hepatitis B immunization strategy, and choose the optimizing immunization strategy.4. The order of the sensitivity of the different parameters involved in the model:HBVM positive rate, the coverage of hepatitis B vaccine, rate of anti-HBs after vaccination, vaccine and vaccination fees, screening fees, discount rate and the costs of HBV-infected.5. The intangible cost of HBV-infected has not found the effect on the order of immunization strategy.Conclusion 1. The strategy of immunization of hepatitis B for people over the age of 15 is that selective vaccination is better than universal vaccination, and the optimizing immunization strategy for people of over 15 years was inoculate three 10μg vaccines after screening the markers anti-HBs, HBsAg and HBc according the program of 0,1 and 6 months.2. Decision tree-Markov model can comprehensive evaluate the hepatitis B immunization strategy, and has good applicability and reliability.3. Parameters of Greater impacting on the model are positive rate HBVM, the coverage of hepatitis B vaccine, rate of anti-HBs after vaccination. Vaccine and vaccination fees, screening fees, discount rate and the costs of HBV-infected have less affected on the model.4. The intangible cost of HBV-infected has not found the effect on the order of immunization strategy.

Related Dissertations

  1. Study on Correlation between TCM Syndrome Types and IFN-γ in Patients with Chronic Hepatitis B,R259
  2. Comparison on Immunoprotective Effect of Bacteriophages of Vibrio Alginolyticus and Vaccines of Bacterial Ghost,S945
  3. The Preliminary Studies on Characteristics of HCV Quasispecies Variation and Its Immune Escaping Mechanism,R392.1
  4. Expression and Purification of Influenza a Virus M2 Protein and Detection of Its Antigenicity,R392
  5. Development of Subunit Vaccine of Streptococcus Suis Type 2 and Actinobacillus Pleuropneumoniae,S858.28
  6. Isolationand Identification of Porcine Parvovirus and Parts of Its Biological Characteristics,S852.65
  7. Studies on the Molecular Mechanism of Anti-HBV Effect of Green Tea Extract Epigallocatechin Gallate,R285
  8. Expression of IBDV Structural Protein VP2 Gene in Bombyx Mori and Its Immune Effect As Subunit Vaccine,S855.3
  9. Molecular Epidemiological Analysis of Duck Hepatitis B Virus in Cherry Valley Duck in Henan Province and Anti-duck Hepatitis B Virus Activities of FNC in Vivo,S858.32
  10. DNA Prime/Protein Boost of Japanse Edcephalitis Virus NS1 Protein to Improve Immune Response in Mice,R392
  11. Retrospective Study on Pathological Results, Four Results of Liver Fiber, and TCM Syndrome Type of 164 CHB Patients,R259
  12. The Application Research of Heparin and Protamine Ratio for the Hepatitis B (or Carriers) Patients Undergoing Valve Replacement Operation,R512.62
  13. The Preliminary Study of the pcDNA3.1(+)-SjP14 Nanometer Microballoon-DNA Vaccines,R392.1
  14. Construction of an Full-Lengh Genomic cDNA Clone of Hev SAAS-JdY5,R346
  15. Saftey Evaluation of Inoculated with Hepatitis A+B Combination Vaccine and Japanese Encephalitis Vaccine in ICR Mice,R186
  16. Edwardsiella Tarda Infection on Andrias Davidianus and the Protection of Dead Vaccine at Primary Immune,R392.1
  17. The Optimization of Manufacturing Process and Verification Technology during the Preparation of Vero Cells of JE Inactivated Vaccine,R392
  18. Preliminary Study of Molecular Epidemiology on Hepatitis B among Certain Regions in Anhui Province,R512.62
  19. The Precise Measurement on Anti-HBc and Anti-HBe Detected by Chemiluminescent Microparticle Immunoassay,R512.6
  20. The Curative Effects of 72-week Entecavir Therapy for Patients with Decompensated Hepatitis B Virus-Related Cirrhosis,R512.62
  21. The Value of MELD Score and Serum Total Cholesterol in Predicting the Prognsis of Patients with Decompensated Liver Cirrhosis Caused by Hepatitis B Virus,R575.2

CLC: > Medicine, health > Basic Medical > Medical Immunology > Immunobiology
© 2012 www.DissertationTopic.Net  Mobile